Terms: = Liver cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Diagnosis
25 results:
1. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
[TBL] [Abstract] [Full Text] [Related]
2. Insights into synchronous peritoneal metastases from hepatobiliary origin: Incidence, risk factors, treatment, and survival from a nationwide database.
Rijken A; Bakkers C; Klümpen HJ; van der Geest LG; de Vos-Geelen J; van Erning FN; de Hingh IHJT
Eur J Surg Oncol; 2023 Aug; 49(8):1436-1443. PubMed ID: 36898900
[TBL] [Abstract] [Full Text] [Related]
3. The potential value of serum GP73 in the ancillary diagnosis and grading of liver cirrhosis.
Hui-Ling C; Kang-Ming H; Yu Z; Yin-Han D; Huang D; Shu-Ping X; Hong-Bin C
Scand J Clin Lab Invest; 2023 Apr; 83(2):95-102. PubMed ID: 36786815
[TBL] [Abstract] [Full Text] [Related]
4. New strategy for liver Imaging Reporting and Data System category M to improve diagnostic performance of MRI for hepatocellular carcinoma ≤ 3.0 cm.
Jang JK; Choi SH; Byun JH; Park SY; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
Abdom Radiol (NY); 2022 Jul; 47(7):2289-2298. PubMed ID: 35523888
[TBL] [Abstract] [Full Text] [Related]
5. Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first-line treatment of systemic light chain amyloidosis in the UK.
Sharpley FA; Manwani R; Petrie A; Mahmood S; Sachchithanantham S; Lachmann HJ; Martinez De Azcona Naharro A; Gillmore JD; Whelan CJ; Fontana M; Cohen O; Hawkins PN; Wechalekar AD
Eur J Haematol; 2021 Apr; 106(4):537-545. PubMed ID: 33460466
[TBL] [Abstract] [Full Text] [Related]
6. Increased Malignancy Rate in Children With IgE Deficiency: A Single-center Experience.
Ferastraoaru D; Schwartz D; Rosenstreich D
J Pediatr Hematol Oncol; 2021 May; 43(4):e472-e477. PubMed ID: 32769562
[TBL] [Abstract] [Full Text] [Related]
7. Primary liver cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy.
Coon C; Berger N; Eastwood D; Tsai S; Christians K; Mogal H; Clarke C; Gamblin TC
Ann Surg Oncol; 2020 Apr; 27(4):1156-1163. PubMed ID: 31677109
[TBL] [Abstract] [Full Text] [Related]
8. The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practice.
Alexandraki KI; Pizanias M; Uri I; Thomas D; Page T; Kolomodi D; Low CS; Adesanya O; Tsoli M; Gross DJ; Randeva H; Srirajaskanthan R; Grozinsky-Glasberg S; Kaltsas G; Weickert MO
Endocrine; 2019 Jun; 64(3):690-701. PubMed ID: 30635793
[TBL] [Abstract] [Full Text] [Related]
9. Type 2 Diabetes and Risk of Incident cancer in China: A Prospective Study Among 0.5 Million Chinese Adults.
Pan XF; He M; Yu C; Lv J; Guo Y; Bian Z; Yang L; Chen Y; Wu T; Chen Z; Pan A; Li L;
Am J Epidemiol; 2018 Jul; 187(7):1380-1391. PubMed ID: 29304221
[TBL] [Abstract] [Full Text] [Related]
10. Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.
Ricco G; Cavallone D; Cosma C; Caviglia GP; Oliveri F; Biasiolo A; Abate ML; Plebani M; Smedile A; Bonino F; Pontisso P; Brunetto MR
Cancer Biomark; 2018 Feb; 21(3):603-612. PubMed ID: 29278878
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of sorafenib in Chinese unresectable hepatocellular carcinoma patients with prior surgery and portal vein tumor thrombosis: A subset analysis of GIDEON study data.
Ye SL; Chen X; Yang J; Bie P; Zhang S; Liu F; Liu L; Zhou J; Dou K; Yip CS; Yang X
Tumour Biol; 2017 Mar; 39(3):1010428317695030. PubMed ID: 28349781
[TBL] [Abstract] [Full Text] [Related]
12. Granulocyte colony-stimulating factor-producing pancreatic anaplastic carcinoma in ascitic fluid at initial diagnosis: A case report.
Kubota N; Naito Y; Kawahara A; Taira T; Yamaguchi T; Yoshida T; Abe H; Takase Y; Fukumitsu C; Murata K; Ishida Y; Okabe Y; Kimura Y; Tanigawa M; Mihara Y; Nakayama M; Yamaguchi R; Akiba J; Yano H
Diagn Cytopathol; 2017 May; 45(5):463-467. PubMed ID: 28185423
[TBL] [Abstract] [Full Text] [Related]
13. Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics.
Bergquist JR; Groeschl RT; Ivanics T; Shubert CR; Habermann EB; Kendrick ML; Farnell MB; Nagorney DM; Truty MJ; Smoot RL
HPB (Oxford); 2016 Nov; 18(11):886-892. PubMed ID: 27546172
[TBL] [Abstract] [Full Text] [Related]
14. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract] [Full Text] [Related]
15. Circulating TGF-β1 and VEGF and risk of cancer among liver transplant recipients.
Engels EA; Jennings L; Kemp TJ; Chaturvedi AK; Pinto LA; Pfeiffer RM; Trotter JF; Acker M; Onaca N; Klintmalm GB
Cancer Med; 2015 Aug; 4(8):1252-7. PubMed ID: 25919050
[TBL] [Abstract] [Full Text] [Related]
16. Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans.
Ladep NG; Dona AC; Lewis MR; Crossey MM; Lemoine M; Okeke E; Shimakawa Y; Duguru M; Njai HF; Fye HK; Taal M; Chetwood J; Kasstan B; Khan SA; Garside DA; Wijeyesekera A; Thillainayagam AV; Banwat E; Thursz MR; Nicholson JK; Njie R; Holmes E; Taylor-Robinson SD
Hepatology; 2014 Oct; 60(4):1291-301. PubMed ID: 24923488
[TBL] [Abstract] [Full Text] [Related]
17. Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors.
Boyar Cetinkaya R; Vatn M; Aabakken L; Bergestuen DS; Thiis-Evensen E
Scand J Gastroenterol; 2014 Jun; 49(6):734-41. PubMed ID: 24679166
[TBL] [Abstract] [Full Text] [Related]
18. Decrypting cryptogenic hepatocellular carcinoma: clinical manifestations, prognostic factors and long-term survival by propensity score model.
Hsu CY; Lee YH; Liu PH; Hsia CY; Huang YH; Lin HC; Chiou YY; Lee FY; Huo TI
PLoS One; 2014; 9(2):e89373. PubMed ID: 24586728
[TBL] [Abstract] [Full Text] [Related]
19. Delayed systemic recurrence of uveal melanoma.
Kolandjian NA; Wei C; Patel SP; Richard JL; Dett T; Papadopoulos NE; Bedikian AY
Am J Clin Oncol; 2013 Oct; 36(5):443-9. PubMed ID: 22706174
[TBL] [Abstract] [Full Text] [Related]
20. Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden.
Foukakis T; Fornander T; Lekberg T; Hellborg H; Adolfsson J; Bergh J
Breast Cancer Res Treat; 2011 Nov; 130(2):553-60. PubMed ID: 21617918
[TBL] [Abstract] [Full Text] [Related]
[Next]
